Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma

Annals of Thoracic Surgery

Volumn 97, Issue 5, 2014, Pages 1734-1741

  Hsu, Po Kuei ^a,b   Huang, Chien Sheng ^a,b   Wang, Bing Yen ^c   Wu, Yu Chung ^a,b   Hsu, Wen Hu ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CONTINUOUS INFUSION; CONTROLLED STUDY; DERMATITIS; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; VOMITING;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899956571     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.12.041     Document Type: Article

References (17)

1. A. Pennathur, M. Gibson, B.A. Jobe, and J.D. Luketich Esophageal carcinoma Lancet 381 2012 400 412
2. Y. Xu, X. Yu, Q. Chen, and W. Mao Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? World J Surg Oncol 10 2012 173
3. B.C. Visser, A.P. Venook, and M.G. Patti Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal Surg Oncol 12 2003 1 7
4. National Comprehensive Cancer Network. Esophageal cancer clinical practice guidelines in oncology. Available at: www.nccn.org. Accessed January 22, 2014.
5. T.W. Rice, D.J. Adelstein, and M.A. Chidel et al. benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma J Thorac Cardiovasc Surg 126 2003 1590 1596
6. E.L.R. Bedard, R.I. Inculet, R.A. Malthaner, E. Brecevic, M. Vincent, and R. Dar The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma Cancer 91 2001 2423 2430
7. P.K. Hsu, C.S. Huang, B.Y. Wang, Y.C. Wu, T.Y. Chou, and W.H. Hsu The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection Ann Thorac Surg 96 2013 995 1001
8. P.K. Hsu, B.Y. Wang, C.S. Huang, Y.C. Wu, and W.H. Hsu Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection J Gastrointest Surg 15 2011 558 565
9. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American Joint Committee on Cancer (AJCC) cancer staging manual 7th ed. 2010 Springer Chicago
10. National Cancer Institute. Common terminology criteria for adverse events v.3.0 (CTCAE). Available at: http://ctep.cancer.gov. Accessed January 22, 2014.
11. G.W. Dittrick, J.M. Weber, and R. Shridhar et al. Pathologic non responders after neoadjuvant chemoradiation for esophageal cancer demonstrated no survival benefit compared with patient treated with primary esophagectomy Ann Surg Oncol 19 2012 1678 1684
12. J. Tepper, M.J. Krasna, and N. Niedzwiecki et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB9781 J Clin Oncol 26 2008 1086 1092
13. P. Van Hagen, M.C. Hulshof, and J.J. van Lanschot et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
14. C. Mariette, J.F. Seitz, and E. Maillard et al. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III FFCD 9901 J Clin Oncol 28 Suppl 15 2010 A-4005
15. S.G. Urba, M.B. Orringer, A. Turrisi, M. Lannettoni, A. Forastiere, and M. Strawderman Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
16. J.S. Macdonald, S.R. Smalley, and J. Benedetti et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
17. S.P. Dexter, H. Sue-Ling, M.J. McMahon, P. Quirke, N. Mapstone, and I.G. Martin Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer Gut 48 2001 667 670